Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

India-Japan trade to treble in three years

India-Japan trade is set to treble in three years, according to Indian Ambassador to US Ronen Sen. India and Japan have set a trade turnover target of $20 billion by 2010, up from last year's figure of about $7.5 billion, in which Japan enjoyed a trade surplus of $1.7 billion, Sen said in his address to the Japan Society here Friday.

Posted: Feb 16th, 2008

Read more

Fluorescent nanoparticles image tumor marker in animals

Since 2004 the U.S. Food and Drug Administration has approved three new-generation anticancer therapies that target epidermal growth factor receptor (EGFR), a protein that is greatly overexpressed on certain types of tumors, including some forms of colorectal and lung cancer. For patients with EGFR-positive tumors, these drugs can be lifesavers, but at present, there is no good way to predict who will respond to anti-EGFR therapy. That may change, though, thanks to the development of two quantum dot-based systems that can image EGFR expression in living animals.

Posted: Feb 15th, 2008

Read more

Targeted dendrimer advances in preclinical studies

Although a variety of nanoparticles continue to show promise for improving cancer imaging and therapy, regulators and drug developers are concerned that these delivery systems may prove difficult to manufacture on a consistent basis, which is key for any agent designed for use in humans. A new study provides data showing that such concerns can be overcome.

Posted: Feb 15th, 2008

Read more

Nanotechnology advances brain cancer detection and therapy

Brain cancer is one of the most aggressive and lethal of malignancies, made even more difficult to treat by the fact that most anticancer drugs have a hard time even getting to the tumors. Now, studies by three different groups of researchers show that targeted nanoparticles hold promise for solving this delivery problem.

Posted: Feb 15th, 2008

Read more

Researchers probe biological fate of carbon nanotubes with Raman spectroscopy

Carbon nanotubes have shown real promise as highly accurate vehicles for delivering antitumor agents into malignant cells, but a dearth of data about what happens to the tubes after they discharge their medical payloads has been a major stumbling block to progress. Now, two studies at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response have revealed some reassuring answers after months of tracking the tiny tubes inside mice.

Posted: Feb 15th, 2008

Read more

RSS Subscribe to our Nanotechnology Research News feed

Nanowerk on Facebook Engage with our Nanotechnology News on Facebook